Whole exome sequencing (WES) of metastatic leiomyosarcoma (LMS) and liposarcoma (LPS) and correlation of genomic aberrations with clinical outcomes in the phase III randomized trial of trabectedin (T) vs. dacarbazine (D)

Abstract only

Saved in:
Bibliographic Details
Published in:Journal of clinical oncology Vol. 36; no. 15_suppl; p. 11513
Main Authors: Kapoor, Gurpreet, Li, Weimin, Shen, Dong, Knoblauch, Roland Elmar, Gormley, Michael, Wang, George C., Ricci, Deborah S., Smith, Michael P., Motley, Clifford, Malbrain, Sigrid, Maki, Robert G., vonMehren, Margaret, Patel, Shreyaskumar, Demetri, George D.
Format: Journal Article
Language:English
Published: 20-05-2018
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract only
ISSN:0732-183X
1527-7755
DOI:10.1200/JCO.2018.36.15_suppl.11513